SELLAS Life Sciences Group, Inc. (SLS) net assets (shareholders' equity)
SELLAS Life Sciences Group, Inc. (SLS) had net assets of $70.87M at the end of fiscal 2025 (December 31, 2025). That is 648.8% higher than the $9.47M of fiscal 2024. Figures as of 18 Nov 2026, 23:36 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Net assets, fiscal 2025
- $70.87M
- Change on fiscal 2024
- +648.8%
- Growth, 5 years
- +20.4% a year
- Highest on record
- $70.87Mfiscal 2025
- Lowest on record
- -$12.26Mfiscal 2015
- Fiscal years on record
- 162010–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
SELLAS Life Sciences Group, Inc. net assets (shareholders' equity), in more detail
Over the five fiscal years to 2025 net assets grew at a compound 20.4% a year. Across the 16 fiscal years on record (2010–2025), the highest was $70.87M in fiscal 2025 and the lowest -$12.26M in fiscal 2015.
Net assets by fiscal year
SELLAS Life Sciences Group, Inc. net assets (shareholders' equity), year by year
| Fiscal year | Net assets | Change | Year ended |
|---|---|---|---|
| 2025 | $70.87M | 648.8% up | |
| 2024 | $9.47M | — | |
| 2023 | -$7.98M | 264.4% down | |
| 2022 | $4.85M | 76.2% down | |
| 2021 | $20.35M | 27.2% down | |
| 2020 | $27.96M | 358.9% up | |
| 2019 | $6.09M | 16.2% up | |
| 2018 | $5.25M | 153.4% up | |
| 2017 | $2.07M | — | |
| 2016 | -$5.00M | — | |
| 2015 | -$12.26M | 133.1% down | |
| 2014 | $37.06M | 529.6% up | |
| 2013 | $5.89M | 78.8% down | |
| 2012 | $27.76M | 174.5% up | |
| 2011 | $10.11M | 316.1% up | |
| 2010 | $2.43M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.
How to read it
Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.
SELLAS Life Sciences Group, Inc., figure by figure
- SELLAS Life Sciences Group, Inc. market cap
- SELLAS Life Sciences Group, Inc. revenue
- SELLAS Life Sciences Group, Inc. earnings
- SELLAS Life Sciences Group, Inc. earnings per share (EPS)
- SELLAS Life Sciences Group, Inc. P/E ratio
- SELLAS Life Sciences Group, Inc. P/S ratio
- SELLAS Life Sciences Group, Inc. P/B ratio
- SELLAS Life Sciences Group, Inc. free cash flow
- SELLAS Life Sciences Group, Inc. operating margin
- SELLAS Life Sciences Group, Inc. dividend
- SELLAS Life Sciences Group, Inc. shares outstanding
- SELLAS Life Sciences Group, Inc. total debt
- SELLAS Life Sciences Group, Inc. cash on hand
- SELLAS Life Sciences Group, Inc. total assets
- SELLAS Life Sciences Group, Inc. total liabilities
- SELLAS Life Sciences Group, Inc. return on equity (ROE)
- SELLAS Life Sciences Group, Inc. return on invested capital (ROIC)
SELLAS Life Sciences Group, Inc. (SLS) overview: price, valuation and scorecard
SELLAS Life Sciences Group, Inc. net assets (shareholders' equity): questions and answers
What are SELLAS Life Sciences Group, Inc.'s net assets?
SELLAS Life Sciences Group, Inc. (SLS) had net assets of $70.87M at the end of fiscal 2025 (December 31, 2025). That is 648.8% higher than the $9.47M of fiscal 2024.
What is the growth rate of SELLAS Life Sciences Group, Inc.'s net assets?
Over the five fiscal years to 2025 net assets grew at a compound 20.4% a year.
What are the highest and lowest net assets figures on record for SELLAS Life Sciences Group, Inc.?
Across the 16 fiscal years on record (2010–2025), the highest was $70.87M in fiscal 2025 and the lowest -$12.26M in fiscal 2015.
How is SELLAS Life Sciences Group, Inc.'s net assets calculated?
Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For SELLAS Life Sciences Group, Inc. it is on record here for 16 fiscal years, 2010 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: net assets (shareholders' equity)
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “SELLAS Life Sciences Group, Inc. (SLS) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/SLS/net-assets
Underlying data: the company's filings with the SEC and Yahoo Finance.